State Drug Administration: will be in accordance with the law in accordance with the special task, the first time to complete the vaccine approval and insurance supply

BEIJING, Oct. 20, in response to China's new crown vaccine when the fastest time to market and other issues, 20, the State Drug Administration Drug Review Center chief reviewer Wang Tao at a press conference, vaccine research and development is subject to a number of factors, of which III clinical trials must be carried out in the affected areas, its progress depends on the number of subjects, the speed of the participants into the group, the speed of infection in the subjects, as well as the results of the trial and other specific circumstances.
Once clinical trials have obtained sufficient clinical data to demonstrate that the vaccine is sufficiently protective and has an acceptable safety basis and stable commercial scale production quality, the applicant can submit a vaccine listing application.
the State Drug Administration will be in accordance with the law, special operations, in the first time to complete the technical review of the vaccine, to ensure safe and effective, controlled quality vaccine as soon as possible on the market.